2021
Use of Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Injured Children
Mahajerin A, Petty JK, Hanson SJ, Shabanova V, Faustino EVS. Use of Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Injured Children. Journal Of Pediatric Hematology/Oncology 2021, 44: e349-e357. PMID: 33885041, DOI: 10.1097/mph.0000000000002167.Peer-Reviewed Original ResearchConceptsReceipt of prophylaxisRisk of VTEVenous thromboembolismInjured childrenRisk prediction modelPharmacologic prophylaxisTrauma Quality Improvement ProgramLow molecular weight heparinHospitalized injured patientsPediatric-specific evidencePractice management guidelinesRandomized clinical trialsMolecular weight heparinQuality Improvement ProgramUnfractionated heparinWeight heparinRetrospective studyInjured patientsClinical trialsProphylaxisManagement guidelinesThromboembolismPatientsHigh rateChildren
2011
Survey of pharmacologic thromboprophylaxis in critically ill children*
Faustino EV, Patel S, Thiagarajan RR, Cook DJ, Northrup V, Randolph AG. Survey of pharmacologic thromboprophylaxis in critically ill children*. Critical Care Medicine 2011, 39: 1773-1778. PMID: 21423003, PMCID: PMC3118917, DOI: 10.1097/ccm.0b013e3182186ec0.Peer-Reviewed Original ResearchConceptsPediatric intensive care unitIntensive care unitCare unitIll childrenPharmacologic thromboprophylaxisPediatric intensive care unit patientsIntensive care unit patientsPresence of hypercoagulabilityDeep venous thrombosisCare unit patientsEvidence-based guidelinesCross-sectional self-administered surveyRigorous randomized trialsMajor bleedingLack of evidenceUnit patientsPatient factorsVenous thrombosisCavopulmonary anastomosisRandomized trialsWeight heparinPediatric intensivistsThromboprophylaxisInfant scenarioInvasive interventions